Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 8 studies | 30% ± 15% | |
basal cell | 5 studies | 28% ± 11% | |
goblet cell | 5 studies | 28% ± 19% | |
respiratory goblet cell | 4 studies | 21% ± 3% | |
classical monocyte | 4 studies | 28% ± 8% | |
secretory cell | 3 studies | 25% ± 8% | |
ciliated cell | 3 studies | 30% ± 11% | |
GABAergic neuron | 3 studies | 43% ± 6% | |
glutamatergic neuron | 3 studies | 45% ± 10% | |
transit amplifying cell | 3 studies | 31% ± 14% | |
astrocyte | 3 studies | 23% ± 2% | |
interneuron | 3 studies | 36% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 4236.86 | 245 / 245 | 100% | 130.08 | 502 / 502 |
stomach | 100% | 4098.38 | 359 / 359 | 100% | 90.20 | 286 / 286 |
intestine | 100% | 3684.31 | 966 / 966 | 100% | 103.28 | 526 / 527 |
kidney | 100% | 4322.31 | 89 / 89 | 100% | 94.37 | 897 / 901 |
lung | 100% | 2856.87 | 576 / 578 | 100% | 133.27 | 1153 / 1155 |
pancreas | 100% | 2010.05 | 328 / 328 | 99% | 75.35 | 177 / 178 |
thymus | 100% | 2586.68 | 652 / 653 | 99% | 62.37 | 600 / 605 |
ovary | 100% | 3492.58 | 180 / 180 | 98% | 49.53 | 423 / 430 |
brain | 98% | 1860.49 | 2601 / 2642 | 100% | 50.14 | 704 / 705 |
uterus | 100% | 2203.05 | 170 / 170 | 98% | 90.58 | 449 / 459 |
bladder | 100% | 3368.81 | 21 / 21 | 97% | 93.92 | 491 / 504 |
breast | 100% | 1688.33 | 457 / 459 | 98% | 84.71 | 1093 / 1118 |
esophagus | 100% | 3316.50 | 1442 / 1445 | 97% | 94.59 | 177 / 183 |
liver | 100% | 2963.79 | 226 / 226 | 96% | 74.56 | 390 / 406 |
skin | 100% | 2797.36 | 1804 / 1809 | 96% | 61.09 | 453 / 472 |
adrenal gland | 100% | 3491.19 | 258 / 258 | 93% | 41.39 | 213 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 64.05 | 29 / 29 |
spleen | 100% | 3295.15 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 44.50 | 1 / 1 |
adipose | 100% | 2012.61 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 2610.61 | 800 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1522.23 | 1327 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 4006.91 | 921 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 110.42 | 44 / 45 |
heart | 95% | 2262.96 | 815 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 86% | 37.00 | 69 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045454 | Biological process | cell redox homeostasis |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0098869 | Biological process | cellular oxidant detoxification |
GO_0006749 | Biological process | glutathione metabolic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0004362 | Molecular function | glutathione-disulfide reductase (NADPH) activity |
GO_0050661 | Molecular function | NADP binding |
GO_0050660 | Molecular function | flavin adenine dinucleotide binding |
GO_0009055 | Molecular function | electron transfer activity |
Gene name | GSR |
Protein name | Glutathione reductase, mitochondrial (GR) (GRase) (EC 1.8.1.7) Glutathione-disulfide reductase |
Synonyms | GLUR GRD1 |
Description | FUNCTION: Maintains high levels of reduced glutathione in the cytosol. |
Accessions | A0A2R8YF59 ENST00000221130.11 [P00390-1] ENST00000537535.5 [P00390-5] A0A2I6B3H4 ENST00000523295.5 ENST00000541648.5 [P00390-4] H0YC68 ENST00000643653.1 P00390 ENST00000546342.5 [P00390-3] |